Natera, Inc. (NTRA) stock
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30138% above fair value
$287.47−1.01 (-0.35%)
Close on Nov 17, 2026Market cap $41.44BP/E –Yield –
Natera cash
Cash and short-term investments held at the end of each period.
Natera's cash was $1.09B at Jun 30, 2026. For fiscal 2025 it was $1.08B, up 11.1% from the year before. Over ten years it grew 43.6% a year on average. The highest annual figure on record is $1.08B in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.08B | +11.1% |
| FY2024 | Dec 31, 2024 | $968.28M | +10.2% |
| FY2023 | Dec 31, 2023 | $878.98M | -2.2% |
| FY2022 | Dec 31, 2022 | $898.39M | -1.8% |
| FY2021 | Dec 31, 2021 | $914.51M | +24.0% |
| FY2020 | Dec 31, 2020 | $737.46M | +67.2% |
| FY2019 | Dec 31, 2019 | $441.05M | +178.3% |
| FY2018 | Dec 31, 2018 | $158.47M | +1117.0% |
| FY2017 | Dec 31, 2017 | $13.02M | -22.0% |
| FY2016 | Dec 31, 2016 | $16.69M | -42.3% |
| FY2015 | Dec 31, 2015 | $28.95M | -66.8% |
| FY2014 | Dec 31, 2014 | $87.18M | +185.9% |
| FY2013 | Dec 31, 2013 | $30.50M | +430.6% |
| FY2012 | Dec 31, 2012 | $5.75M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.09B | +7.4% |
| Q1 FY2026 | Mar 31, 2026 | $1.09B | +9.7% |
| Q4 FY2025 | Dec 31, 2025 | $1.08B | +11.1% |
| Q3 FY2025 | Sep 30, 2025 | $1.04B | +13.0% |
| Q2 FY2025 | Jun 30, 2025 | $1.02B | +14.5% |
| Q1 FY2025 | Mar 31, 2025 | $991.60M | +12.3% |
| Q4 FY2024 | Dec 31, 2024 | $968.28M | +10.2% |
| Q3 FY2024 | Sep 30, 2024 | $922.33M | -1.5% |
| Q2 FY2024 | Jun 30, 2024 | $887.10M | +20.5% |
| Q1 FY2024 | Mar 31, 2024 | $882.94M | +8.7% |
| Q4 FY2023 | Dec 31, 2023 | $878.98M | -2.2% |
| Q3 FY2023 | Sep 30, 2023 | $936.56M | +79.7% |
| Q2 FY2023 | Jun 30, 2023 | $735.94M | +15.2% |
| Q1 FY2023 | Mar 31, 2023 | $812.01M | +8.0% |
| Q4 FY2022 | Dec 31, 2022 | $898.39M | -1.8% |
| Q3 FY2022 | Sep 30, 2022 | $521.24M | -49.1% |
| Q2 FY2022 | Jun 30, 2022 | $638.74M | +10.0% |
| Q1 FY2022 | Mar 31, 2022 | $752.19M | +15.1% |
| Q4 FY2021 | Dec 31, 2021 | $914.51M | +24.0% |
| Q3 FY2021 | Sep 30, 2021 | $1.02B | +26.5% |
| Q2 FY2021 | Jun 30, 2021 | $580.47M | +1.6% |
| Q1 FY2021 | Mar 31, 2021 | $653.74M | +61.1% |
| Q4 FY2020 | Dec 31, 2020 | $737.46M | +67.2% |
| Q3 FY2020 | Sep 30, 2020 | $809.73M | +1467.3% |
| Q2 FY2020 | Jun 30, 2020 | $571.23M | +1805.2% |
| Q1 FY2020 | Mar 31, 2020 | $405.88M | +1070.4% |
| Q4 FY2019 | Dec 31, 2019 | $441.05M | +178.3% |
| Q3 FY2019 | Sep 30, 2019 | $51.66M | +32.1% |
| Q2 FY2019 | Jun 30, 2019 | $29.98M | +64.2% |
| Q1 FY2019 | Mar 31, 2019 | $34.68M | -12.6% |
| Q4 FY2018 | Dec 31, 2018 | $158.47M | +1117.0% |
| Q3 FY2018 | Sep 30, 2018 | $39.10M | +248.8% |
| Q2 FY2018 | Jun 30, 2018 | $18.26M | +155.8% |
| Q1 FY2018 | Mar 31, 2018 | $39.69M | +336.8% |
| Q4 FY2017 | Dec 31, 2017 | $13.02M | -22.0% |
| Q3 FY2017 | Sep 30, 2017 | $11.21M | -55.7% |
| Q2 FY2017 | Jun 30, 2017 | $7.14M | – |
| Q1 FY2017 | Mar 31, 2017 | $9.09M | – |
| Q4 FY2016 | Dec 31, 2016 | $16.69M | – |
| Q3 FY2016 | Sep 30, 2016 | $25.32M | – |
See a number that looks wrong?